During the past decade, Norton Pulmonary Specialists conducted 12 clinical trials. In the 10-year time frame, 12 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 11 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Norton Pulmonary Specialists" #1 sponsor was "Acceleron Pharma Inc. (a wholly owned subsidiary of Merck Sharp and Dohme, a subsidiary of Merck & Co., Inc.)" with 2 trials, followed by "Actelion" with 2 trials sponsored, "GB002, Inc., a wholly owned subsidiary of Gossamer Bio, Inc." with 2 trials sponsored, "Altavant Sciences GmbH" with 1 trials sponsored and "Bayer" with 1 trials sponsored. Other sponsors include 0 different institutions and companies that sponsored additional 10 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Norton Pulmonary Specialists" #1 collaborator was "Xcenda, LLC" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Norton Pulmonary Specialists" are "Pulmonary Arterial Hypertension" (7 trials), "Hypertension, Pulmonary" (2 trials), "Chronic Bronchitis" (1 trials), "Idiopathic Pulmonary Fibrosis" (1 trials) and "Interstitial Lung Disease" (1 trials). Many other conditions were trialed in "Norton Pulmonary Specialists" in a lesser frequency.

Most popular intervention types in "Norton Pulmonary Specialists" are "Drug" (8 trials), "Device" (4 trials), "Biological" (1 trials), "Combination Product" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (6 trials), "Generic Dry Powder Inhaler" (2 trials), "Blood Sample" (1 trials), "GB002" (1 trials) and "GB002 (seralutinib)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Norton Pulmonary Specialists" are 13 trials for "All" genders.

Currently, there are NaN active trials in "Norton Pulmonary Specialists". undefined are not yet recruiting, 8 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Norton Pulmonary Specialists, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Norton Pulmonary Specialists, 1 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".